AOBiome competitorsClear all

AOBiome's top competitors include Vyome Biosciences, Oncologie, Lion TCR and Veloxis Pharmaceuticals.
AOBiome
AOBiome
AOBiome is a pioneer in bacterial therapy. We represent a new approach to skin health that focuses on the restoring good bacteria to your biome
Vyome Biosciences
Vyome Biosciences
Vyome Biosciences is a biopharmaceutical company engaged in the development of novel drugs for antibiotic-resistant acne and other opportunist pathogens.
Oncologie
Oncologie
Oncologie is a biopharmaceutical company.
Lion TCR
Lion TCR
Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases.
Veloxis Pharmaceuticals
Veloxis Pharmaceuticals
Veloxis Pharmaceuticals is a biopharmaceutical company, which identifies, develops, and commercializes products that are used in transplantation and adjacent therapies.
Founding Date
Founding Date
2013
Founding Date
2010
Founding Date
2018
Founding Date
N/A
Founding Date
2002
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Cambridge, US
Locations
Boston, US HQ
Delhi, IN
Vadodara, IN
Princeton, US
Locations
Boston, US HQ
Shanghai, CN
Locations
Singapore, SG HQ
Guangzhou, CN
Singapore, SG
Locations
København, DK HQ
Cary, US
Employees
Employees
17
Employees
30
Employees
343% increase
Employees
N/A
Employees
54
Twitter followers
Twitter followers
1.5 k
Twitter followers
172
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
280011
Alexa Website Rank
281031
Alexa Website Rank
N/A
Alexa Website Rank
408854
Alexa Website Rank
330809
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A

Funding

Latest funding round
Latest funding round
$ 30m (over 3 years ago)
Latest funding round
$ 21.9m (over 1 year ago)
Latest funding round
$ 80m (over 1 year ago)
Latest funding round
$ 20m (over 2 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 38.7m
Total funding raised
$ 48.2m
Total funding raised
$ 96.5m
Total funding raised
$ 20m
Total funding raised
$ 60m
For sources of this data, please see the company profile

View company profiles

Vyome Biosciences
HQ
Boston, US
Employees
30

Vyome Biosciences is a biopharmaceutical company engaged in the development of novel drugs for antibiotic-resistant acne and other opportunist pathogens.

View company
Oncologie
HQ
Boston, US
Employees
34↑ 3% increase

Oncologie is a biopharmaceutical company.

View company
Lion TCR
HQ
Singapore, SG

Lion TCR is a clinical-stage biotechnology company that develops TCR-T cell therapy for cancers and life-threatening infectious diseases.

View company
Veloxis Pharmaceuticals
HQ
København, DK
Employees
54

Veloxis Pharmaceuticals is a biopharmaceutical company, which identifies, develops, and commercializes products that are used in transplantation and adjacent therapies.

View company